About the Soft Tissue Sarcoma Session
Soft tissue sarcoma (STS) encompasses a heterogeneous group of cancers originating in connective tissues like muscle, fat, and nerves. Despite its rarity compared to other cancers, STS presents challenges in diagnosis and treatment due to its diverse subtypes and complex biology. Research in this field aims to elucidate the underlying genetic and molecular mechanisms driving STS development and progression. Novel therapeutic approaches, including targeted therapies and immunotherapies, are being explored to improve outcomes for STS patients. Additionally, advancements in imaging techniques and biomarker identification hold promise for early detection and personalized treatment strategies. Collaborative efforts between researchers, clinicians, and patients are crucial in advancing our understanding and management of this complex disease.
Topics Covered in Soft Tissue Sarcoma
Liposarcoma
Leiomyosarcoma
Retroperitoneal Sarcoma
Molecular Diagnostics
Preoperative Radiotherapy
Targeted Therapies
Related Scientific Sessions at CIOC 2027
Why Attend the Soft Tissue Sarcoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Soft Tissue Sarcoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Soft Tissue Sarcoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Soft Tissue Sarcoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Soft Tissue Sarcoma Conference 2027 — FAQs
What is the Soft Tissue Sarcoma track at CIOC 2027?
The Soft Tissue Sarcoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Soft Tissue Sarcoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Soft Tissue Sarcoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Soft Tissue Sarcoma are all welcome — whether presenting or attending.
Can I present my research in the Soft Tissue Sarcoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Soft Tissue Sarcoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Soft Tissue Sarcoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.